article thumbnail

Hsa?miR?503?5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells

Chemical Biology and Drug Design

Hsa-miR-503-5p expression in LUAD and the target gene downstream of hsa-miR-503-5p was predicted by bioinformatics analysis. The results showed that hsa-miR-503-5p showed high expression, while its target gene CTDSPL presented decreased expression in LUAD.

article thumbnail

Hederagenin inhibits high glucose?induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression

Chemical Biology and Drug Design

Hederagenin attenuated HG-induced increase in mRNA and protein expression of NLRP3, ASC, and IL-1β. Bioinformatics analysis predicted cathepsin B (CTSB) as a target of hederagenin to modulate NOD-like receptor (NLR) pathway. Hederagenin also suppressed HG-induced increase in mRNA and secretion levels of FN, Col.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Plumbagin induces apoptosis, cell cycle arrest, and inhibits protein synthesis in LoVo colon cancer cells: A proteomic analysis

Chemical Biology and Drug Design

A label-free proteomics technology was employed to investigate alterations in protein expression in LoVo cells treated with plumbagin. The LC-MS/MS proteomics assay revealed 78 proteins that were differentially expressed upon treatment with plumbagin.

article thumbnail

ADCs: the next generation of targeted therapies 

Drug Discovery World

DISCO’s approach is to analyse the “surfaceome” of cancer cells – the totality of all proteins expressed on the cell surface – looking for ways that diseased tissue is differentiated from normal tissue. Ries noted that there are other things to think about aside from finding targets expressed only on tumour cells. .”

Therapies 162
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Cell line and systems engineering The sixth track of PEGS Europe 2023 is Cell Line and Systems Engineering, which will feature a range of sessions made up of presentations, talks and posters which cover applying data science to enhance protein expression, and engineering and developing host cell lines. Claes Gustafsson, Ph.D,

article thumbnail

Finding the right CDMO partner for cell line development

Drug Target Review

Together, these attributes provide a strong foundation for protein expression with enough adaptability to produce much of the commercial and therapeutic protein market.

article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It